Neurogene Inc. NGNE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-03-07
Neurogene Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 1,394,714 | $50.8M |
| CITADEL ADVISORS LLC | 413,231 | $8.3M |
| MILLENNIUM MANAGEMENT LLC | 204,809 | $4.1M |
| RENAISSANCE TECHNOLOGIES LLC | 43,400 | $874,944 |
| TWO SIGMA INVESTMENTS, LP | 13,891 | $280,043 |
| AQR CAPITAL MANAGEMENT LLC | 10,311 | $207,870 |
Source: SEC EDGAR filings · CIK 0001404644 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.